You are here:

Carduso Capital B.V.

Carduso Capital participates in technology companies that are preferably based on the know-how represented in and originating from the Groningen science cluster in and around the University of Groningen (RUG) and the University Medical Center Groningen (UMCG).

Companies in portfolio of Carduso Capital B.V.

About Carduso Capital B.V.

Investments in innovative technology companies
Carduso Capital invests in innovative technology companies with strong affiliations with the University of Groningen (RUG), the University Medical Center Groningen (UMCG) and knowledge institutes in their network. These can be spin-offs or start-ups as well as established companies that wish to extend based on their technological know-how, research and collaborations with the RUG and the UMCG. Emphasis is on companies in the focus areas Life Sciences, Energy and Sustainable Society. RUG and UMCG are co-initiators of Carduso Capital.

Venture capital for promising technology companies
Carduso Capital invests in promising technology companies looking for venture capital to be able to grow. Carduso Capital knows exactly what phases these companies will be going through. To meet the different financing needs in each phase, Carduso Capital has created an internal Seed facility with an adjusted investment scope.
Carduso Capital aims at long-term cooperation with the companies in which it invests. In order to support success, multiple investment rounds can be financed, if necessary – either alone or together with other investors.

Active participation adds value
In addition to financing, Carduso Capital also deploys management support, strategic knowledge and our broad network. This has major added value. Carduso Capital’s active participation yields added value and transformation of knowledge in cost-effective technology companies. Entrepreneurs are actively supported in realising their plans and trying to achieve an attractive return for everyone involved.

Carduso Capital selection criteria
The products and services of the companies in Groningen in which Carduso invests satisfy unmet needs that can be easily grasped based on realistic assumptions, schedules and scenarios. Inventions by emerging companies, start-ups and university spin-offs:

  • Have a completed proof of concept.
  • Have been worked out in a functional prototype.
  • Are expected to enter the commercial market shortly.

Carduso Capital’s investment scope depends on the phase of the company, but ranges from a minimum of €100K to a maximum of €5,000K per investment.

People make the difference
People are crucial for the success of any company. Employers, initiators and management of the companies in which we invest are highly qualified professionals willing to work with the company in the long term, also in difficult times. After all, these adventures never form a straight line to success.

View other funds from the IFG

The Acquisitiefonds Groningen (Groningen Acquisition Fund, AFG) invests in companies that intend to move to and do busin...
Cottonwood Technology Fund is an early stage fund that invests in deeptech/hard science startups with patented disruptiv...
The fund is always looking for emerging companies and start-ups with a well thought-out IT proposition who wish to locat...
Berk Partners Groeifonds invests in existing, fast-growing Dutch SME companies, mainly in the following industries: inno...
Borski Fund: We believe in diversity, gender equality and fair chances. We believe there should be more female entrepren...
NextGen Ventures 2 invests in knowledge-intensive data-driven companies that are changing healthcare – preferably ...
Campus Groningen is the fastest-growing campus in the Netherlands, relying on the facilities available for SMEs. Investm...
The focus of Dutch Security TechFund lies on early stage companies, start-ups and later-stage companies active in cyber ...


CapitalT is a (pre-)seed fund that invests in companies which use AI to solve real world problems in climate tech, educa...
Investment fund Pharma Connect Capital (PCC) invests in very early-stage medicine development, drug delivery and biomark...